CIK 0001847367 · <br>Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- 4 Open-market sale Chief Legal Officer sold 5,000 shares at $28.00 ($140,000)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 3,553 shares (grant or award)
- 4 Grant or award Director acquired 3,553 shares (grant or award)
- 4 Grant or award Director acquired 3,553 shares (grant or award)
- 4 Grant or award Director acquired 3,553 shares (grant or award)
- 4 Grant or award Director acquired 3,553 shares (grant or award)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Option exercise Chief Medical Officer acquired 26,852 shares (option exercise)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Other disposition 10% owner disposed of 2,299,807 shares (other)
- 4 Other disposition 10% owner disposed of 2,299,807 shares (other)
- 4 Other disposition Director disposed of 2,299,807 shares (other)
Page 2 of 13 · 248 filings